Amish Desai, MD
Interventional Cardiology · Portland, ORNPI 1134282932
Payments from drug & device makers
Across 722 payments — averaging $922.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$312K
- Boston Scientific$274K
- Abbott$64K
- Medical Device Business Services, Inc.$12K
- Abiomed$2K
- Shockwave Medical, Inc$488
- plus $1K from 22 others
What the payments were for
- Consulting fees$30,65016%
- Speaking & faculty fees$115,72562%
- Travel & lodging$18,36110%
- Food & beverage$21,34711%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 191 | $311,728 |
| Boston Scientific | 340 | $274,500 |
| Abbott | 70 | $63,993 |
| Medical Device Business Services, Inc. | 5 | $11,650 |
| Abiomed | 63 | $2,326 |
| Shockwave Medical, Inc | 8 | $488 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $171 |
| Philips North America LLC | 5 | $148 |
| AMAG Pharmaceuticals, Inc. | 1 | $87 |
| Endotronix, Inc. | 1 | $83 |
| E.r. Squibb & Sons, L.L.C. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $66 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $65 |
| Novartis | 1 | $64 |
| Amgen | 4 | $62 |
| Recor Medical Inc | 1 | $54 |
| AstraZeneca | 3 | $47 |
| Pfizer | 2 | $46 |
| Teleflex LLC | 2 | $44 |
| Acist Medical Systems, Inc. | 1 | $38 |
| Merck | 1 | $32 |
| W. L. Gore & Associates, Inc. | 1 | $28 |
| Cvrx, Inc. | 1 | $25 |
| Heartflow, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $16 |
| Catheter Precision Inc. | 1 | $14 |
| Cordis US CORP. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$78,195
- WATCHMAN Access System$58,392
- WATCHMAN FLX$14,773
- GENERAL - THERAPIES$9,233
- VersaCross Access Solution$6,353
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,682
- PASCAL$342
- SAPIEN 3 Ultra RESILIA$177
- MitraClip System$169
- Vascular Lithotripsy$160
- Edwards SAPIEN XT Transcatheter Heart Valve$154
- Impella$137
- Mitra Clip system$122
- COMET$115
- Trifecta GT Tissue Heart Valve$111
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$108
- AVVIGO Guidance System$104
How this compares
$665,906 in reported general payments places this provider in the 90th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $22,414 |
| ClopidogrelClopidogrel Bisulfate | 53 | $490 |
| Prednisone | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $46 | $22,41442 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 68 interventional cardiology providers in Oregon.
Other interventional cardiology in Portland
- Harsh GolwalaPortland$1.3M
- Ethan KorngoldPortland$1.1M
- Jason WollmuthPortland$945K
- Brandon JonesPortland$739K
- Robert HodsonPortland$482K
- Logan VincentPortland$106K
- Richard SohnPortland$101K
- Kathryn DawsonPortland$57K
- Amged AbdelazizPortland$38K
- Daniel FeldmanPortland$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.